UBS Initiates Option Care Health(OPCH.US) With Hold Rating, Announces Target Price $26
Critical Insights From Option Care Health Analyst Ratings: What You Need To Know
Option Care Health Initiated at Neutral by UBS
UBS Initiates Coverage On Option Care Health With Neutral Rating, Announces Price Target of $26
Option Care Health Analyst Ratings
Truist Financial Maintains Option Care Health(OPCH.US) With Buy Rating, Maintains Target Price $34
Option Care Health (OPCH) Gets a Buy From Truist Financial
Jefferies Maintains Option Care Health(OPCH.US) With Hold Rating, Maintains Target Price $26
Jefferies Remains a Hold on Option Care Health (OPCH)
UnitedHealth's Effort to Buy Another Home Health Provider at Risk Amid DOJ Lawsuit
Truist Financial Maintains Option Care Health(OPCH.US) With Buy Rating, Maintains Target Price $34
Option Care Health Analyst Ratings
Goldman Sachs Downgrades Option Care Health(OPCH.US) to Hold Rating, Cuts Target Price to $27
Option Care Health Downgraded to Neutral at Goldman on Stelara Headwinds
Option Care Health Downgraded to Neutral From Buy at Goldman Sachs
A Quick Look at Today's Ratings for Option Care Health(OPCH.US), With a Forecast Between $26 to $34
Option Care Health Price Target Cut to $32.00/Share From $40.00 by Barrington Research
Option Care Health Is Maintained at Outperform by Barrington Research
Truist Financial Maintains Option Care Health(OPCH.US) With Buy Rating, Announces Target Price $34
Option Care Health Cut to Hold From Buy by Jefferies